Prognostic factors in patients with papillary thyroid carcinoma

Journal of Endocrinological Investigation

Volumn 31, Issue 11, 2008, Pages 1032-1037

  Soyluk, O ^a   Selcukbiricik, F ^a   Erbil, Y ^a   Bozbora, A ^a   Kapran, Y ^a   Ozbey, N ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Metastasis; Papillary microcancer; Prognosis; Survival; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

EID: 59849084609     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345644     Document Type: Article

References (18)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998, 338: 297-306.
2. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001, 86: 1447-63.
3. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992, 164: 658-61.
4. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976, 184: 541-53.
5. Lerch H, Saur HB. Significance of lymph node metastases in differentiated thyroid carcinoma. Nuklearmedizin 1995, 34: 203-6.
6. Coburn MC, Wanebo HJ. Prognostic factors and management consideration in patients with cervical metastases of thyroid cancer. Am J Surg 1992, 164: 671-6.
7. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981, 70: 511-8.
8. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000, 7: 229-39.
9. Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res 1991, 51: 1234-41.
10. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994, 18: 559-67.
11. Lundgren KI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006, 106: 524-31.
12. Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine replete endemic goiter region. Endocr Relat Cancer 2004, 11: 131-9.
13. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter. Study of 299 cases. J Clin Endocrinol Metab 2004, 89: 3713-20.
14. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005, 90: 5723-9.
15. Rouxel A, Hejblum G, Bernier MO, et al. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2004, 89: 5362-8.
16. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. A systematic review and metanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004, 89: 3668-76.
17. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97: 418-28.
18. Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 2007, 32: 440-4.